CLDF Title
Home | Contact Us | Bookmark
  HBV   HCC   HCV   HE   NASH   PBC   THROMBOCYTOPENIA
Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights

Target Audience:

This activity has been designed to meet the educational needs of hepatologists, gastroenterologists, and other healthcare professionals involved in the management of patients with common complications of cirrhosis, such as hepatic encephalopathy (HE), thrombocytopenia, and hepatorenal syndrome (HRS).

Goal Statement:

The primary goal of this CME symposium is to better understand how to effectively identify, manage, and treat patients with complications of cirrhosis.

Educational Objectives:

After completing this program, participants should be better able to:

  • Recognize the signs of complications caused by cirrhosis and the impact of current therapeutic interventions
  • Describe evolving patient management strategies for patients with cirrhosis
  • Apply the latest evidence-based treatment strategies to optimize outcomes for patients with cirrhosis

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest:

All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF) have no relationships to disclose.

Learner Assurance Statement:

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Americans with Disabilities Act:

The event staff will be glad to assist you with any special needs (i.e., physical, dietary). Please contact us prior to the event at 1-888-565-5321.

Accredited by

Provided by

Supported by educational grants from Dova Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, and Salix Pharmaceuticals.
This program is not affiliated with Digestive Disease Week ® .

Join the discussion at  

Our Interactive CME Dinner Symposium! 

AMA PRA Category 1 Credits ™

Sunday,
May 19, 2019
Manchester Grand Hyatt

Seaport Ballroom F-G-H

1 Market Place
San Diego, CA 92101

6:00 PM
CME DINNER SYMPOSIUM:
6:30 - 8:00 PM

On-site registration is available.
Space is limited, so please arrive by 6:00 PM.
Seating is on a first-come, first-served basis.

SELECT A SPEAKER TO VIEW THEIR BIO.

FEATURING

Agenda

6:00 PM   

Registration/Seating/Buffet Dinner

6:30 PM   

Welcome and Introduction
Kimberly Brown, MD, FAST, FAASLD, AGAF

6:35 PM   

Breaking News in Chronic Liver Disease
Kimberly Brown, MD, FAST, FAASLD, AGAF

6:50 PM   

Clinical Case Forum I: Current and Emerging Management Approaches for the Cirrhotic Patient
with Thrombocytopenia
Sammy Saab, MD, MPH, AGAF, FAASLD, FACG

7:10 PM   

Clinical Case Forum II: Current and Emerging Management Approaches
for the Patient with Hepatorenal Syndrome
R. Todd Frederick, MD

7:30 PM   

Clinical Case Forum III: Current Management Approaches for the Patient with Hepatic Encephalopathy
Steven Flamm, MD, FAASLD, FACG

7:50 PM   

Expert Panel Discussion and Q&A

8:00 PM   

Closing Remarks

Back to the Agenda
KIMBERLY A. BROWN, MD, FAST, FAASLD, AGAF

Professor of Medicine, Wayne State University
Chief, Gastroenterology and Hepatology
Associate Medical Director, Henry Ford Hospital Transplant Institute
Henry Ford Hospital
Detroit, Michigan

Dr. Kimberly A. Brown is the chief of Gastroenterology and Hepatology at Henry Ford Hospital in Detroit. She joined the Henry Ford Medical Group in 1995 as medical director of the Liver Transplant Program and was appointed chief of the Division of Gastroenterology and Hepatology in 2003. In addition, she served as the program director for the GI Fellowship Program from 2003 to 2008. In 2016, she was appointed as the associate medical director for the Henry Ford Hospital Transplant Institute.

Dr. Brown received her undergraduate degree from the University of Michigan in 1981. She completed her medical degree at Wayne State University in 1985. Dr. Brown completed both her residency in internal medicine, as well as her fellowship in gastroenterology, at the University of Michigan in 1992 and was named chief medical resident in 1984-85.

Dr. Brown is a member of the American Gastroenterology Association, the American Association for the Study of Liver Disease, the American College of Gastroenterology, and the American Society of Transplantation. She served on the Board of Governors of the Henry Ford Medical Group for nine years, the Henry Ford Hospital and System Network Board, and was past co-chair of the Michigan Chapter of the American Liver Foundation. She was a founding board member for the ABIM Liver Transplantation and Advanced Hepatology Board. She is past treasurer and board member of the American Society of Transplantation and is involved in several committees for both the Society and hospital. She is a past member of the UNOS Liver and Intestines Committee and previously served on the executive board for the Liver and Intestines Community of Practice for the AST. She is past associate editor for the CLDF journal. Currently, Dr. Brown is the secretary for the AASLD and serves on multiple committees in that capacity.

As chief of Gastroenterology and Hepatology and past medical director of Liver Transplantation, Dr. Brown sees and manages patients with complex liver disease both before and after liver transplantation. In conjunction with Dr. Abouljoud, she worked to develop the leading liver transplant program in the State of Michigan. As fellowship director, she managed a fellowship program of 16 GI/liver fellows and continues to be involved in structuring and monitoring their education and academic success. Dr. Brown has trained over 110 fellows in advanced hepatology and transplantation. She has published over 70 articles, 110 abstracts, and eight book chapters/reviews and is a very active clinical investigator in viral hepatitis, advanced liver disease, and post liver-transplant management.

Speaker Disclosure

Honoraria recipient:Gilead, Pfizer, and Merck.

Research to Institution:Allergan, Conatus, Gilead, and Novartis.

Back to the Agenda
STEVEN FLAMM, MD, FAASLD, FACG

Chief of Hepatology and the Liver Transplantation Program
Professor of Medicine and Surgery
Northwestern Feinberg School of Medicine
Chicago, Illinois

Steven L. Flamm, MD is a professor of medicine and surgery with the Division of Hepatology at Northwestern University Feinberg School of Medicine in Chicago, Illinois. He serves as the chief of transplantation hepatology and medical director of liver transplantation.

Dr. Flamm received his MD degree from the University of Pennsylvania School of Medicine. He completed internal medicine training, a chief medical residency year, a clinical fellowship in gastroenterology, and a research fellowship in gastroenterology and hepatology at Beth Israel Hospital, Harvard Medical School, including a specialized year of training in liver transplantation at The Deaconess Hospital, Harvard Medical School.

Dr. Flamm is a member of the American Gastroenterological Association (AGA), the American Association for the Study of Liver Diseases (AASLD), and is a fellow at the American College of Gastroenterology (ACG). He has served as the Region 7 Representative to the UNOS Liver and Intestine Committee and on the Publication and Practice Guidelines Committees of the AASLD. Currently, he is a trustee of the AASLD Foundation and chair of the AASLD Development Committee. Dr. Flamm is also currently a member of the Clinical Practice Guidelines Committee of the AGA, the Research Committee of the ACG, and the Illinois Hepatitis C State Task Force. He serves on the editorial board of Gastroenterology and Hepatology and is the chair of an AGA abstract review committee.

Dr. Flamm has been the invited editor of three issues of Clinics in Liver Disease and was also the 2015 American Liver Foundation Illinois Chapter Honoree.
Dr. Flamm has published widely in the field of hepatic diseases and has spoken both nationally and internationally on many liver-related topics including viral hepatitis, autoimmune hepatitis, primary biliary cholangitis, hepatic encephalopathy, and liver transplantation. He has an active clinical research program for patients with many different chronic liver diseases, including chronic viral hepatitis (HBV and HCV), hepatic encephalopathy, acute liver failure, primary biliary cholangitis, and non-alcoholic fatty liver disease (NAFLD).

Speaker Disclosure

Consultant: Intercept and Salix Pharmaceuticals.

Back to the Agenda
R. TODD FREDERICK, MD

Transplant Hepatologist
San Francisco Center for Liver Disease
California Pacific Medical Center
San Francisco, California

Dr. R. Todd Frederick is a transplant hepatologist with the San Francisco Center for Liver Disease at California Pacific Medical Center. He currently serves as clinical director of Hepatology and fellowship director for Transplant Hepatology, as well as the chair of the Clinical Protocols Committee for the Division.

Dr. Frederick received his undergraduate degree in biology from the University of California, Los Angeles and his medical degree from New York Medical College in Valhalla, New York. He completed both his internal medicine residency and his fellowship in gastroenterology/hepatology at the University of California, San Diego. His clinical and research interests include the management of advanced chronic liver disease and liver failure, artificial liver support systems, hepatorenal syndrome, and portal hypertension, among other topics.

Speaker Disclosure

Research Support: Mallinckrodt.

Consultant:Dova, Evidera, Mallinckrodt, Morphocell, Salix Pharmaceuticals, Shionogi and Vital Therapies.

Back to the Agenda
SAMMY SAAB, MD, MPH, AGAF, FAASLD, FACG

Professor of Medicine and Surgery
Adjunct Professor of Nursing
Head, Outcomes Research in Hepatology
David Geffen School of Medicine at UCLA
Los Angeles, California

Dr. Sammy Saab is a professor in the departments of Internal Medicine and Surgery at the David Geffen School of Medicine. He is also head of outcomes research in hepatology at the Pfleger Liver Institute.

Dr. Saab received his BS, MD, and MPH degrees from UCLA. He completed his residency in internal medicine at the University of California at San Diego (UCSD) Medical Center and a fellowship in gastroenterology/hepatology at the UCLA Center for Health Sciences. He also served as chief medical resident at USCD. Dr. Saab is board certified in gastroenterology and transplant hepatology.
He has received honorary fellowship from several medical societies, including the American Gastroenterology Association (AGAF), the American Association for the Study of Liver Diseases (FAASLD), and the American College of Gastroenterology (ACG).

Dr. Saab is active in many local, national, and international committees. He served on the Medical Advisory Committee of the Ventura County/ West Valley Chapter of TRIO (2005-2012), Practice Guidelines Committee of the American Society of Transplantation (2006-2008), and the Educational Committee of the American Association for the Study of Liver Diseases (2004-2007). He is currently on the local and national medical board for the American Liver Foundation.

Dr. Saab was elected to the American Association for the Study of Liver Diseases Nominating Committee in 2014. He previously served as a member of the United Network for Organ Sharing Membership and Professional Standards Committee and Performance Analysis and Improvement Subcommittee . Dr. Saab was also an active member of the Minority Affairs Committee Member and Cultural Diversity for the American College of Gastroenterology.

Dr. Saab has been an investigator in numerous clinical trials, a frequently invited speaker worldwide, and leads an annual patient education seminar.

He has been named one of the "Best Doctors in America" and has received the Distinguished Achievement Award from his Division of Digestive Diseases.

Dr. Saab has published over 300 peer-reviewed manuscripts. He has authored many book chapters, editorials, abstracts, and poster presentations.

Dr. Saab is on the editorial board of more than a dozen journals and is currently the Liver Section editor for the Journal of Clinical Gastroenterology.

Speaker Disclosure

Research Support: Conatus.

Speakers Bureau:AbbVie, Bayer, BMS, Dova, Eisai, Elixis, Gilead, Intercept and Salix Pharmaceuticals.

Consultant:AbbVie, Bayer, Dova, Eisai, Elixis, Gilead, Intercept, and Salix Pharmaceuticals.

                               
 
HBV
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
 
HE
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
 
OTHER
Webcasts
Slide Library
   
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
             
CLDF Follow Us
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.